A new high-yield continuous cell-culture system for lymphokine-activated killer cells
- PMID: 2598170
- PMCID: PMC11038978
- DOI: 10.1007/BF01665023
A new high-yield continuous cell-culture system for lymphokine-activated killer cells
Abstract
We performed basic studies on a new high-yield culture system (concentrate rotary tissue-culture system) for application to adoptive immunotherapy with lymphokine-activated killer (LAK) cells. Using this system, we demonstrated that up to 2 x 10(7) peripheral blood mononuclear cells/ml could be cultured in interleukin-2 with a sufficient recovery rate and cytotoxicity in short-term cultures (6 days). This system can also be used to proliferate LAK cells to four times the initial cell number with sufficient cytotoxicity for 14 days of culture. Thus, this system allows activation of sufficient numbers of cells to conduct clinical trials on humans.
Similar articles
-
A high density cell culture system for generation of human lymphokine-activated killer (LAK) cells for clinical use in adoptive immunotherapy.J Clin Lab Immunol. 1990 May;32(1):41-7. J Clin Lab Immunol. 1990. PMID: 1967036
-
[Application of a new compact and cell dense continuous culture system for LAK cells generated from cryo-preserved lymphocytes].Nihon Gan Chiryo Gakkai Shi. 1990 Mar 20;25(3):598-602. Nihon Gan Chiryo Gakkai Shi. 1990. PMID: 2351852 Japanese.
-
Augmentation of cell number and LAK activity in peripheral blood mononuclear cells activated with anti-CD3 and interleukin-2. Preliminary results in children with acute lymphocytic leukemia and neuroblastoma.Cancer Immunol Immunother. 1988;27(1):82-8. doi: 10.1007/BF00205763. Cancer Immunol Immunother. 1988. PMID: 3260824 Free PMC article.
-
Human lymphokine-activated killer (LAK) cells. I. Depletion of monocytes from peripheral blood mononuclear cells by L-phenylalanine methyl ester: an optimization of LAK cell generation at high cell density.Cancer Immunol Immunother. 1989;30(4):247-53. doi: 10.1007/BF01665012. Cancer Immunol Immunother. 1989. PMID: 2598193 Free PMC article.
-
Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor.Cancer. 1995 Oct 1;76(7):1253-60. doi: 10.1002/1097-0142(19951001)76:7<1253::aid-cncr2820760724>3.0.co;2-f. Cancer. 1995. PMID: 8630906
Cited by
-
A new culture system for the cultivation of mammalian cells for the production of several biologically active substances.Cytotechnology. 1993;13(2):143-8. doi: 10.1007/BF00749941. Cytotechnology. 1993. PMID: 7764579
-
Macrophage-T cell interaction is essential for the induction of p75 interleukin 2 (IL-2) receptor and IL-2 responsiveness in human CD4+ T cells.Jpn J Cancer Res. 1991 Mar;82(3):257-61. doi: 10.1111/j.1349-7006.1991.tb01839.x. Jpn J Cancer Res. 1991. PMID: 1902447 Free PMC article.
-
Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.Br J Cancer. 1992 Jul;66(1):20-6. doi: 10.1038/bjc.1992.210. Br J Cancer. 1992. PMID: 1353365 Free PMC article.
References
-
- Fisher RI, Coltman CA, Jr, Doroshow JH, Rayner AA, Hawkins MJ, Mier JW, Wiernik P, McMannis JD, Weiss GR, Margolin KA, Gemlo BT, Hoth DF, Parkinson DR, Paietta E. Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial. Ann Int Med. 1988;108:518. - PubMed
-
- Kangas L, Gronroos M, Nieminen AL. Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro. Med Biol. 1984;62:338. - PubMed
-
- Kato K, Yamada T, Kawahara K, Onda H, Asano T, Sugino H, Kakinuma A. Purification and characterization of recombinant human interleukin-2 produced inEscherichia coli . Biochem Biophys Res Commun. 1985;130:692. - PubMed
-
- McElroy WD, DeLuca MA. The chemistry and applications of firefly luminescence. New York: Academic Press; 1981. Bioluminescence and chemiluminescence. Basic chemistry and analytical applications; p. 179.
-
- Muul LM, Director EP, Hyatt CL, Rosenberg SA. Large scale production of human lymphokine activated killer cells for use in adoptive immunotherapy. J Immunol Methods. 1986;88:265. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources